Template:Available forms of testosterone

v
t
e
Available forms of testosterone^[a]
Route	Ingredient	Form	Dose^[b]	Brand names^[c]
Oral	Test. undecanoate	Capsule	40 mg	Andriol, Jatenzo
Sublingual	Testosterone	Tablet	10 mg	Testoral
Buccal	Testosterone	Tablet	30 mg	Striant
Intranasal	Testosterone	Nasal gel	5.5 mg/spray, 120 sprays	Natesto
Transdermal	Testosterone	Non-scrotal patch	2.5, 4, 5, 6 mg/day	Androderm
		Non-scrotal patch	150, 300 μg/day	Intrinsa
		Scrotal patch^[d]	4, 6 mg/day	Testoderm
		Topical gel	25, 50, 75, 100, 125 mg/pump	AndroGel, Testim
		Axillary solution	30 mg/pump	Axiron
Rectal	Testosterone	Suppository	40 mg	Rektandron
Injection^[e]	Test. enanthate	Oil solution	50, 100, 180, 200, 250 mg/mL	Delatestryl
	Test. cypionate	Oil solution	50, 100, 200, 250 mg/mL	Depo-Testosterone
	Mixed test. esters^[f]	Oil solution	100, 250 mg/mL	Sustanon
	Test. undecanoate	Oil solution	750, 1000 mg	Aveed, Nebido
Implant	Testosterone	Pellet	50, 75, 100, 200 mg	Testopel
Footnotes and sources: ^ This table does not include combination products with other medications/hormones. The availability of specific products may vary by country - see Testosterone (medication) § Availability. ^ These dosages may be given at varying frequencies - dosages listed are "each" (ex: per tablet, per spray, etc) and not indicative of total daily dose or equivalent. ^ Other brand names may be currently or historically marketed. ^ Potentially discontinued. ^ May be by intramuscular injection or subcutaneous injection. ^ Combination of testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, and testosterone decanoate. Sources: ^[1]^[2]^[3]^[4]^[5]^[6]^[7]^[8]^[9]^[10]^[11]^[12]^[13]^[14]

[1] This table does not include combination products with other medications/hormones. The availability of specific products may vary by country - see Testosterone (medication) § Availability.

[2] These dosages may be given at varying frequencies - dosages listed are "each" (ex: per tablet, per spray, etc) and not indicative of total daily dose or equivalent.

[3] Other brand names may be currently or historically marketed.

[dc-4] Potentially discontinued.

[5] May be by intramuscular injection or subcutaneous injection.

[6] Combination of testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, and testosterone decanoate.

[pmid16918944-7] Nieschlag E (September 2006). "Testosterone treatment comes of age: new options for hypogonadal men". Clin. Endocrinol. (Oxf). 65 (3): 275–81. doi:10.1111/j.1365-2265.2006.02618.x. PMID 16918944.

[pmid25617174-8] Nieschlag E (January 2015). "Current topics in testosterone replacement of hypogonadal men". Best Pract. Res. Clin. Endocrinol. Metab. 29 (1): 77–90. doi:10.1016/j.beem.2014.09.008. PMID 25617174.

[pmid12906378-9] Byrne M, Nieschlag E (May 2003). "Testosterone replacement therapy in male hypogonadism". J. Endocrinol. Invest. 26 (5): 481–9. doi:10.1007/bf03345206. PMID 12906378.

[CappaCianfarani2015-10] Cappa M, Cianfarani S, Ghizzoni L, Loche S, Maghnie M (10 December 2015). Advanced Therapies in Pediatric Endocrinology and Diabetology: Workshop, Rome, October 2014. Karger Medical and Scientific Publishers. pp. 68–. ISBN 978-3-318-05637-2.

[Drugs@FDA-11] "Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Archived from the original on November 16, 2016. Retrieved November 16, 2016.

[Melmed2016-12] Melmed S (1 January 2016). Williams Textbook of Endocrinology. Elsevier Health Sciences. pp. 760–769. ISBN 978-0-323-29738-7.

[Lenehan2003-13] Lenehan P (12 June 2003). Anabolic Steroids. CRC Press. pp. 108–109. ISBN 978-0-415-28029-7.

[Becker2001-14] Becker KL (2001). Principles and Practice of Endocrinology and Metabolism. Lippincott Williams & Wilkins. pp. 1116, 1119, 1152, 1182–1185, 1195–1197, 2146. ISBN 978-0-7817-1750-2. Archived from the original on May 5, 2017.

[NieschlagBehre2012-15] Nieschlag E, Behre HM (6 December 2012). Testosterone: Action - Deficiency - Substitution. Springer Science & Business Media. pp. 1–, 9, 298, 309–331, 349–353, 366–367. ISBN 978-3-642-72185-4.

[KrishnaShah1996-16] Krishna UR, Sheriar NR, Mandecklar A (1996). Menopause. Orient Blackswan. pp. 70–. ISBN 978-81-250-0910-8.

[Brotherton1976-17] Brotherton J (1976). Sex Hormone Pharmacology. Academic Press. pp. 18–19, 331, 336. ISBN 978-0-12-137250-7.

[WellsDiPiro2014-18] Wells BG, DiPiro JT, Schwinghammer TL, DiPiro CV (22 August 2014). Pharmacotherapy Handbook, 9/E. McGraw-Hill Education. p. 288. ISBN 978-0-07-182129-2.

[Lauritzen1988-19] Lauritzen C (1988). "Natürliche und Synthetische Sexualhormone – Biologische Grundlagen und Behandlungsprinzipien" [Natural and Synthetic Sexual Hormones – Biological Basis and Medical Treatment Principles]. In Schneider HP, Lauritzen C, Nieschlag E (eds.). Grundlagen und Klinik der Menschlichen Fortpflanzung [Foundations and Clinic of Human Reproduction] (in German). Walter de Gruyter. pp. 229–306. ISBN 978-3110109689. OCLC 35483492.

[Apotekens1964-20] Apotekens informationsavdelning (1964). Apotekens synonymregister över farmacevtiska specialiteter. Apotekens informationsavdelning. Rektandron FERRING supp. 40 mg • individ. dos. • 10 st.

[a]

[b]

[c]

[d]

[e]

[f]

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

[14]

Template:Available forms of testosterone

See also

References